PROTEASE INHIBITOR (PI)
Lexiva is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with other antiretroviral medications. Lexiva is also referred to by its drug name, Fosamprenavir, and by the abbreviations FOS-APV or FPV.
Lexiva is an antiviral medication of the protease inhibitor (PI) class. Lexiva is believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Lexiva is taken once or twice daily.
Lexiva comes in tablet and oral suspension forms.
The FDA-approved label for Lexiva lists common side effects including headache, nausea, diarrhea, vomiting, fatigue, and pain in the stomach or abdomen.
Rare but serious side effects listed for Lexiva include severe skin reactions.
For more details about this treatment, visit:
Lexiva – RxList
Overview of HIV Treatments – AIDS.gov